Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease

QR Code

Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease

None

Saved in:

Bibliographic Details
Main Author:	Huri, Hasniza Zaman
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27493
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)

New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors
by: V. V. Syvolap, et al.
Published: (2014-04-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
by: N. В. Perepech, et al.
Published: (2018-05-01)

THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS AFTER CORONARY STENTING IN PATIENTS WITH UNSTABLE ANGINA AND RESISTANCE TO ANTIPLATELET AGENTS
by: E. A. Medvedeva, et al.
Published: (2017-12-01)

Dyslipidemia and Cardiovascular Disease
by: Fakhrzadeh, Hossein, et al.
Published: (2012)

Implications of Type II Diabetes Mellitus on Gastrointestinal Cancers
by: Yu, Diana H., et al.
Published: (2011)

Diabetic retinopathy and dyslipidemia among patients with type 2 diabetes mellitus in the Jazan endocrine and diabetes center: A case-control study
by: Mansor Bayydih, et al.
Published: (2025-06-01)

Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment
by: E. A. Palferova
Published: (2008-02-01)

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
by: E. Y. Kitaeva, et al.
Published: (2017-04-01)

ANTIPLATELET CONTROL OF VESSELS OVER THE MAIN BLOOD CELLS IN HYPERTENSIVES WITH DYSLIPIDEMIA IN COMPLEX THERAPY
by: I. A. Skorjatina, et al.
Published: (2017-04-01)

DIABETES MELLITUS 2ND TYPE WITH CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2015-09-01)

DYSLIPIDEMIA IN NEWBORNS FROM WOMEN WITH GESTATIONAL DIABETES MELLITUS: ARE THE LIPID TRANSPORT SYSTEMS DISRUPTED?
by: Светлана Юрьевна Захарова, et al.
Published: (2025-05-01)

Development and validation of the Tuberculosis Diabetes Mellitus-Predictive Tool (TBDM-PT) in primary care
by: Muhammad Ikhwan Ismail, et al.
Published: (2025-06-01)

The role of modern antithrombotic agents in cardiovascular disease prevention
by: O. M. Drapkina, et al.
Published: (1970-01-01)

Type 2 Diabetes Mellitus in Family Practice: Prevention and Screening
by: Evans, Philip, et al.
Published: (2011)

History of alternative preventive therapies for type 1 diabetes mellitus
by: T. S. Khobotkova, et al.
Published: (2025-02-01)

Concerns and recommendations: antiplatelet agents and cancer prevention in non-alcoholic fatty liver disease
by: Hong Tham Pham, et al.
Published: (2025-07-01)

THE POSSIBILITY OF REDUCING CARDIOVASCULAR RISK IN PATIENTS WITH DIABETES MELLITUS TYPE 2
by: article Editorial
Published: (2017-10-01)

Comparative effectiveness of antiplatelet therapy of hemostatic disorders in diabetes of the second type
by: S. A. Pavlishcuk, et al.
Published: (2015-08-01)

PRAVASTATIN IN CORRECTION OF VESSEL WALL ANTIPLATELET CONTROL OVER THE BLOOD CELLS IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2014-12-01)

ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: E. V. Gorjacheva, et al.
Published: (2016-01-01)

Prevention of gestational diabetes mellitus
by: N. V. Artymuk, et al.
Published: (2023-09-01)

ANTIPLATELET THERAPY IN THE PREVENTION OF CEREBROVASCULAR ACCIDENTS
by: O. V. Rodionova, et al.
Published: (2017-03-01)

Therapeutic education of patients with Type 2 diabetes mellitus and high cardiovascular risk
by: E. A. Palferova, et al.
Published: (2007-12-01)

Type 1 Diabetes Mellitus: Redefining the Future of Cardiovascular Complications with Novel Treatments
by: Bikhazi, Anwar B., et al.
Published: (2011)

Significance of dyslipidemia for primary open-angle glaucoma
by: C. Erb, et al.
Published: (2022-09-01)

THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY
by: D. A. Andreev
Published: (2015-09-01)

Prevention of diabetes mellitus : report of a WHO study group.
Published: (1994)

Dyslipidemia and Cardiovascular Risk: Lipid Ratios as Risk Factors for Cardiovascular Disease
by: Pereira, Telmo
Published: (2012)

PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE
by: M. N. Mamedov, et al.
Published: (2015-12-01)

DIABETIC RETINOPATHY AT THE DIABETES MELLITUS TYPE 1
by: E. B. Balzhinimayev, et al.
Published: (2012-11-01)

DIABETES MELLITUS AND CARDIOVASCULAR COMPLICATIONS: FOCUS ON HEMOSTASIS
by: G. G. Petrik, et al.
Published: (2014-03-01)

Ocular Risk Factors in the Primary Formation of Diabetic Macular Edema in Patients with Type 2 Diabetes Mellitus
by: M. V. Pshenichnov, et al.
Published: (2019-06-01)

Intraocular Risk Factors in the Primary Formation of Diabetic Macular Edema in Patients with Diabetes Mellitus Type II
by: M. V. Pshenichnov, et al.
Published: (2019-03-01)

Antiplatelet Therapy in Cardiovascular Disease – Past, Present and Future
by: Brizzio, Mariano E.
Published: (2012)

CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE
by: I. E. Sapozhnikova, et al.
Published: (2016-01-01)

Pathogenesis, treatment, and prevention of arterial hypertension in Type 2 diabetes mellitus patients
by: V. S. Volkov, et al.
Published: (2008-06-01)

DIABETES MELLITUS TYPE 2 TREATMENT IN CHILDREN AND ADOLESCENTS: METFORMIN AS A FIRST AGENT OF CHOICE
by: T. L. Kuraeva
Published: (2012-01-01)

Safety of Contrast Agents Administration in Patients with Type 2 Diabetes Mellitus During Metformin Intake
by: V. E. Sinitsin, et al.
Published: (2024-05-01)

Dextrans as anticoagulants and antiplatelet agents: protocol for a scoping review
by: Laurence Weinberg, et al.
Published: (2025-06-01)